Veracyte (VCYT) Acquisitions (2014 - 2024)

Veracyte's (VCYT) quarterly Acquisitions came in at -$5.0 million in Q1 2024, down 100.87% quarter-over-quarter from $574.4 million in Q1 2021.

Veracyte (VCYT) Acquisitions (2014 - 2024) Analysis & Trends

Veracyte has disclosed Acquisitions across 3 years of filings, most recently posting -$5.0 million for Q1 2024.

Acquisitions for Q1 2024 came in at -$5.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was -$5.0 million (changed N/A YoY), and the FY2024 annual result was -$5.0 million, changed N/A from the prior year.
Acquisitions came in at -$5.0 million for Q1 2024 at Veracyte, down from $574.4 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $574.4 million in Q1 2021 to a low of -$5.0 million in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Waters	29,902.70 Bn	29,902.24 Bn	1.11 Bn	144.00 Mn
2	Thermo Fisher Scientific	175.99 Bn	172.74 Bn	7.74 Bn	8.87 Bn
3	Danaher	129.87 Bn	124.18 Bn	3.59 Bn	-
4	Idexx Laboratories	44.75 Bn	44.55 Bn	722.74 Mn	-
5	Agilent Technologies	37.52 Bn	35.72 Bn	990.00 Mn	-
6	Iqvia Holdings	30.91 Bn	28.94 Bn	1.36 Bn	37.00 Mn
7	Natera	30.21 Bn	29.11 Bn	696.04 Mn	-
8	Illumina	24.19 Bn	23.04 Bn	721.00 Mn	415.00 Mn
9	Mettler Toledo International	23.12 Bn	23.06 Bn	555.82 Mn	2.24 Mn
10	Veracyte	3.75 Bn	3.49 Bn	101.16 Mn	-

Download Data